Ablation vs Antiarrhythmic Drug Therapy for Symptomatic Ventricular Tachycardias: Is the Debate Over?
J Am Coll Cardiol
.
2022 Sep 6;80(10):e77.
doi: 10.1016/j.jacc.2022.05.057.
Authors
Karim Benali
,
Raphaël P Martins
,
Charles Guenancia
,
Antoine Da Costa
,
Christian de Chillou
PMID:
36049810
DOI:
10.1016/j.jacc.2022.05.057
No abstract available
Publication types
Letter
Comment
MeSH terms
Anti-Arrhythmia Agents / therapeutic use
Catheter Ablation*
Humans
Tachycardia, Ventricular* / drug therapy
Tachycardia, Ventricular* / surgery
Substances
Anti-Arrhythmia Agents